P61 Patient perspectives on switching to an infliximab biosimilar in paediatric inflammatory bowel disease (PIBD) | Archives of Disease in Childhood

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via RCPCH

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Abstracts from the Neonatal and Paediatric Pharmacists Conference November 2019

Sutton Coldfield, UK

P61 Patient perspectives on switching to an infliximab biosimilar in paediatric inflammatory bowel disease (PIBD)

Free

Online download statistics by month:

Online download statistics by month: August 2020 to March 2024

	Abstract	Full	Pdf
Aug 2020	195	0	21
Sep 2020	125	0	13
Oct 2020	50	0	4
Nov 2020	9	0	2
Dec 2020	22	0	3
Jan 2021	14	0	5
Feb 2021	11	0	3
Mar 2021	16	0	5
Apr 2021	13	0	1
May 2021	6	0	1
Jul 2021	0	0	4
Aug 2021	0	0	1
Sep 2021	0	0	3
Oct 2021	2	0	12
Nov 2021	16	0	14
Dec 2021	4	0	0
Jan 2022	12	0	1
Feb 2022	8	0	2
Mar 2022	22	0	4
Apr 2022	12	0	1
May 2022	30	0	6
Jun 2022	57	0	3
Jul 2022	18	0	1
Aug 2022	20	0	3
Sep 2022	16	0	6
Oct 2022	22	0	1
Nov 2022	4	0	1
Dec 2022	8	0	1
Jan 2023	6	0	4
Feb 2023	2	0	0
Mar 2023	5	0	3
Apr 2023	9	0	2
May 2023	15	0	4
Jun 2023	22	0	1
Jul 2023	8	0	4
Aug 2023	0	0	2
Sep 2023	5	0	1
Oct 2023	13	0	1
Nov 2023	14	0	1
Dec 2023	22	0	1
Feb 2024	0	0	2
Mar 2024	6	0	14
Total	839	0	162